ISAMOLTAN

Investigational

Details

Stereochemistry	RACEMIC
Molecular Formula	C16H22N2O2
Molecular Weight	274.3581
Optical Activity	( + / - )
Defined Stereocenters	0 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

SMILES

CC(C)NCC(O)COC1=CC=CC=C1N2C=CC=C2

InChI

InChIKey=XVTVPGKWYHWYAD-UHFFFAOYSA-N

InChI=1S/C16H22N2O2/c1-13(2)17-11-14(19)12-20-16-8-4-3-7-15(16)18-9-5-6-10-18/h3-10,13-14,17,19H,11-12H2,1-2H3

HIDE SMILES / InChI

Molecular Formula	C16H22N2O2
Molecular Weight	274.3581
Charge	0
Count	MOL RATIO 1 MOL RATIO (average)

Stereochemistry	RACEMIC
Additional Stereochemistry	No
Defined Stereocenters	0 / 1
E/Z Centers	0
Optical Activity	( + / - )

Description

Isamoltan (CGP 361A) is a β-adrenoceptor and serotonin 1B receptor antagonist. Isamoltane has reported activity as an anxiolytic in man. Isamoltan had been in phase III clinical trials for the treatment of anxiety. However, this research has been discontinued.

CNS Activity

Originator

Approval Year

Targets

Primary Target	Pharmacology	Condition	Potency
Serotonin 1b (5-HT1b) receptor 46	Antagonist 2,778		40.0 nM [IC50]

Conditions

Condition	Modality	Targets	Highest Phase	Product
Anxiety 267	Primary		Phase III 656	Unknown

Sourcing

Sourcing

Show entries

Vendor/Aggregator	ID	URL
001 Chemical	DY559992	https://www.001chemical.com/chem/55050-95-8
AAA Chemistry	AR-1I1934
ABI Chem	AC1L2RY4
ABI Chem	AC1Q77JG
BOC Sciences	55050-95-8	https://www.bocsci.com/isamoltane-hemifumarate-cas-55050-95-8-item-26946.html

Showing 1 to 5 of 14 entries

Previous1 2 3Next

PubMed

Show entries

Title	Date	PubMed
Neuronal expression and regulation of CGRP promoter activity following viral gene transfer into cultured trigeminal ganglia neurons.	2004 Jan 30	14715155
Endogenously released 5-hydroxytryptamine depresses the spinal monosynaptic reflex via 5-HT1D receptors.	2004 Oct 25	15496296
The antidepressant effects of curcumin in the forced swimming test involve 5-HT1 and 5-HT2 receptors.	2008 Jan 6	17942093
5-HT(1B) receptor regulation of serotonin (5-HT) release by endogenous 5-HT in the substantia nigra.	2010 Jan 13	19819310

Showing 1 to 4 of 4 entries

Previous1Next

Patents

Sample Use Guides

In Vivo Use Guide

Rats: 3 mg/kg, i.p.

Route of Administration: Intraperitoneal

In Vitro Use Guide

Racemic isamoltane showed a selective interaction with the 5-HT1B receptor, having an IC50 value of approximately 40 nmol/l irrespective of whether [125I]ICYP or [3H]5-HT was used as ligand.